Browser storage is unavailable. Keep this page open and export your collection before leaving.
Sourced product detail plus founders, customers, workflow, pricing, origins or business model.
Probably Genetic is changing the lives of patients living with severe, complex diseases. Our data platform is used by drug developers and patient advocacy groups to develop and launch treatments for these patients. Our technology…
Customers · Founders · Product · How it works
AI-powered chemical synthesis platform. Plan complex routes, design experiments, and automate lab workflows.
Customers · Founders · Product · How it works
Automated CDMO for Regenerative Medicines + Developer of iDEM automated tissue production systems. Scale to thousands of patients in months, at 40% lower cost. iDEM technology, UK facility.
Founders · Product · How it works
Designer cell therapies for pets first and their people next.
Founders · Product · How it works
Harbor is clinical trial software built for compliance and designed for humans. Get better data, quicker answers, and faster submissions.
Founders · Product · How it works
While modern AI excels in any area you can collect a lot of data for, it struggles in areas where data is sparse or costly to attain. Designing new molecules, discovering new physics, and engineering new materials are all domains where…
Founders · Product · How it works
Mindstate Design Labs is building the closed-loop science & engineering stack for rational psychoactive effect design. Our molecular-experience interface links molecular biology to the human psychopharmacodynamic profile to convert…
Founders · Product · How it works
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in diverse populations.
Customers · Founders · Product
The next decade is going to see a biotech revolution fueled by three technologies: ability to read DNA (sequencing), ability to write DNA (synthesis), and computational systems that predict what DNA to read and write. With sequencing…
Customers · Founders · Product
We use AI and computational modeling to design advanced antibodies, helping biotech and pharma partners accelerate innovation and improve therapeutic outcomes.
Founders · Product · How it works
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right…
Founders · Product · How it works
Panacea combines an ex-FDA regulatory team with a specialized in-house AI platform to accelerate your FDA approval across 510(k), De Novo, PMA, IND, NDA and BLA pathways.
Founders · Product · How it works
Custom affinity reagents, designed for your target and application. Medium Biosciences designs experimentally validated affinity reagents in weeks, not months.
Founders · Product
In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell…
Founders · Product
Engage Quinn across discovery, development, portfolio and commercial strategy. Research, data analysis, models and designs, with comprehensive reports in 3–5 days after approval.
Founders · Product
Numerion Labs is an AI-native company accelerating the discovery of life-saving medicines through the development and use of cutting-edge machine learning algorithms. The company unites computational chemistry, structural biology, and…
Founders · Product
Parallel Bio is pioneering human-first drug discovery by creating the first map of human biology. Using groundbreaking biological and computational tools that track real clinical outcomes, the company generates data that enable earlier…
Founders · Product
Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first…
Founders · Product
The traditional manufacturing process for individualized drugs is extremely slow and expensive, because it is based on manual labor. At Multiply Labs, we believe that robotics is the only way to truly scale the production of…
Product · How it works
Connect pooled genetic perturbations to single-cell imaging phenotypes with ARADIA™ technology.
Founders · Product
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already…
Founders · Product
Future Fields sustainable, insect-based recombinant protein manufacturing solutions. Our EntoEngine expresses difficult proteins for biotech, agriculture & food innovators.
Founders · Product
At dNovo, we are curing hair loss by creating new hair, de novo. We are doing this with cellular reprogramming technology that we pioneered at Stanford and Harvard. With this technology, we can take any patient derived cell, whether it…
Founders · Product
Reticular is a reproductive-genetics company that provides pregnancy-loss genetic screening for people TTC and IVF.
Founders · Product
